시장보고서

상품코드

1363265

안과용 의료영상저장전송시스템(PACS) 시장 규모, 점유율 및 동향 분석 보고서 : 유형별, 작용기전별, 최종 용도별, 지역별, 부문별 예측(2023-2030년)

Ophthalmology PACS Market Size, Share & Trends Analysis Report By Type (Integrated, Standalone), By Mode Of Action (Cloud-based, On-premise), By End-use (Hospitals, Specialty Clinics), By Region, And Segment Forecasts, 2023 - 2030

발행일: 2023년 09월 | 리서치사:

Grand View Research | 페이지 정보: 영문 105 Pages | 배송안내 : 2-10일 (영업일 기준)

샘플 요청 목록에 추가

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

안과용 의료영상저장전송시스템(PACS) 시장의 성장과 동향 :

Grand View Research, Inc.의 최신 보고서에 따르면, 세계 안과 PACS 시장 규모는 2023년부터 2030년까지 연평균 7.3%로 확대되어 2030년에는 2억 4,860만 달러에 달할 것으로 예상됩니다.

또한 백내장, 녹내장, 노인성 황반변성, 당뇨망막병증과 같은 안과 질환의 유병률 증가는 가까운 미래에 안과용 의료영상저장전송시스템(PACS)에 대한 수요를 촉진할 것으로 예상됩니다. 싱가포르국립대학교 안과는 싱가포르국립대학교 의료시스템 및 남중앙아시아와 공동으로 조사를 실시했습니다. 이 조사에 따르면 2013년 녹내장 환자 수는 1,706만 명으로 2040년에는 약 3,290만 명에 달할 것으로 예상했습니다.

제품 개발, 지리적 확장, M&A는 이 시장에서 주요 기업들이 채택하고 있는 지속 가능한 전략입니다. 예를 들어, 2017년 8월 칼자이스 메디텍(Carl Zeiss Meditec Inc.)은 임상 성과와 업무 효율성을 극대화하는 클라우드 기반 플랫폼을 제공하는 미국 의료 소프트웨어 회사인 Veracity Innovations, LLC를 인수했습니다. 이 플랫폼은 안과 의사들이 환자들에게 개인화된 기술 기반 치료를 제공하는 데 도움을 주고 있습니다. 이번 인수는 기존 회사의 안과 의료 기반 디지털 솔루션 포트폴리오를 확장하기 위한 것입니다. 또한, 아시아태평양의 환자 수가 많은 만큼 이 지역에서의 사업 확장에도 주력하고 있습니다.

안과용 의료영상저장전송시스템(PACS) 시장 보고서 하이라이트

안과 질환 환자 증가, 숙련된 안과 의사 부족, 선진국의 원격 안과 솔루션 사용 확대가 시장을 견인하는 요인입니다.
클라우드 기반 PACS는 상호 운용성 및 상호 성능, 개인 정보 보호 및 보안, 오류 감소, 품질 향상 등의 특성으로 인해 예측 기간 동안 유리한 성장을 기록할 것으로 예상됩니다.
북미는 이 지역의 안과 질환 부담 증가와 공공 및 민간 기업의 의료비 지출 증가로 인해 2022년 시장 점유율을 차지할 것으로 예상됩니다.
아시아태평양은 녹내장 유병률 증가와 효과적인 진단 솔루션에 대한 높은 수요로 인해 예측 기간 동안 가장 높은 CAGR을 기록할 것으로 예상됩니다.
Carl Zeiss Meditec AG, Topcon Corp. 및 Merge Healthcare, Inc.
이들 기업 중 상당수는 사업 확장 전략의 일환으로 기술 발전, M&A, R&D에 집중하고 있습니다.

The global ophthalmology PACS market size is expected to reach USD 248.6 million by 2030, expanding at a CAGR of 7.3% from 2023 to 2030, according to a new report by Grand View Research, Inc.. Moreover, rising prevalence of eye diseases, such as cataract, glaucoma, age-related macular degeneration, and diabetic retinopathy, is expected to fuel demand for ophthalmology PACS in near future. The Department of Ophthalmology of National University of Singapore conducted a study in collaboration with National University Health System, Singapore and South Central Asia. According to this study, the number of glaucoma cases diagnosed in 2013 was 17.06 million, which is anticipated to reach around 32.9 million by 2040.

Product development, geographical expansion and M&A are some sustainability strategies adopted by major companies in this market. For instance, in August 2017, Carl Zeiss Meditec Inc., acquired Veracity Innovations, LLC, a U.S.-based medical software company that delivers cloud-based platforms to maximize clinical performance and work efficiency. These platforms help ophthalmologists in delivering personalized technology-enabled care to their patients. The acquisition is intended to expand the former company's eye care-based digital solutions portfolio. The company is also focusing on expanding the business in Asia Pacific owing to larger patient pool in this region.

Ophthalmology PACS Market Report Highlights:

Increasing cases of ophthalmic diseases, lack of skilled ophthalmologists, and growing usage of teleophthalmology solutions in developed countries are the factors driving the market
Cloud-based PACS is anticipated to register lucrative growth during the forecast period owing to features, such as interoperability and mutual performance, privacy and security, reduced errors, and improved quality
North America held the major share of the market in 2022 due to increased ophthalmic disease burden and healthcare expenditure by public and private firms in this region
Asia-Pacific is anticipated to register the highest CAGR during forecast period due to rising prevalence of glaucoma coupled with high demand for an effective diagnostic solution
Carl Zeiss Meditec AG; Topcon Corp.; Merge Healthcare, Inc. are the major companies in the global ophthalmology PACS market
Most of these companies are focusing on technological advancements, M&A, and R&D as part of their business expansion strategies

Chapter 1. Methodology and Scope

1.1. Market Segmentation & Scope
- 1.1.1. Type
- 1.1.2. Mode of action
- 1.1.3. End-use
- 1.1.4. Regional scope
- 1.1.5. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
- 1.3.1. Purchased database
- 1.3.2. GVR's internal database
- 1.3.3. Secondary sources
- 1.3.4. Primary research
- 1.3.5. Details of primary research
1.4. Information or Data Analysis
1.5. Market Formulation & Validation
1.6. Model Details
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives

Chapter 2. Executive Summary

2.1. Market Outlook
2.2. Segment Outlook
- 2.2.1. Type outlook
- 2.2.2. Mode of action outlook
- 2.2.3. End-use outlook
- 2.2.4. Regional outlook
2.3. Competitive Insights

Chapter 3. Ophthalmology PACS Market Variables, Trends & Scope

3.1. Market Lineage Outlook
- 3.1.1. Parent market outlook
- 3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
- 3.2.1. Market driver analysis
- 3.2.2. Market restraint analysis
3.3. Ophthalmology PACS Market Analysis Tools
- 3.3.1. Industry Analysis - Porter's
  - 3.3.1.1. Supplier power
  - 3.3.1.2. Buyer power
  - 3.3.1.3. Substitution threat
  - 3.3.1.4. Threat of new entrant
  - 3.3.1.5. Competitive rivalry
- 3.3.2. PESTEL Analysis
  - 3.3.2.1. Political landscape
  - 3.3.2.2. Technological landscape
  - 3.3.2.3. Economic landscape

Chapter 4. Ophthalmology PACS: Type Estimates & Trend Analysis

4.1. Ophthalmology PACS Market: Key Takeaways
4.2. Ophthalmology PACS Market: Movement & Market Share Analysis, 2022 & 2030
4.3. Standalone PACS
- 4.3.1. Standalone PACS market estimates and forecasts, 2018 to 2030 (USD Million)
4.4. Integrated PACS
- 4.4.1. Integrated PACS market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. Ophthalmology PACS: Mode of Action Estimates & Trend Analysis

5.1. Ophthalmology PACS Market: Key Takeaways
5.2. Ophthalmology PACS Market: Movement & Market Share Analysis, 2022 & 2030
5.3. On-Premise System
- 5.3.1. On-premise system market estimates and forecasts, 2018 to 2030 (USD Million)
5.4. Cloud-based System
- 5.4.1. Cloud-based system market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 6. Ophthalmology PACS: End-use Estimates & Trend Analysis

6.1. Ophthalmology PACS Market: Key Takeaways
6.2. Ophthalmology PACS Market: Movement & Market Share Analysis, 2022 & 2030
6.3. Hospital
- 6.3.1. Hospital market estimates and forecasts, 2018 to 2030 (USD Million)
6.4. Specialty Clinics
- 6.4.1. Specialty clinics delivery market estimates and forecasts, 2018 to 2030 (USD Million)
6.5. Others
- 6.5.1. Others management market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 7. Ophthalmology PACS Market: Regional Estimates & Trend Analysis

7.1. Regional Outlook
7.2. Ophthalmology PACS Market by Region: Key Takeaways
7.3. North America
- 7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.3.2. U.S.
  - 7.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.3.3. Canada
  - 7.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.4. Europe
- 7.4.1. UK
  - 7.4.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.4.2. Germany
  - 7.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.4.3. France
  - 7.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.4.4. Italy
  - 7.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.4.5. Spain
  - 7.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.4.6. Denmark
  - 7.4.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.4.7. Sweden
  - 7.4.7.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.4.8. Norway
  - 7.4.8.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.5. Asia Pacific
- 7.5.1. Japan
  - 7.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.5.2. China
  - 7.5.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.5.3. India
  - 7.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.5.4. Australia
  - 7.5.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.5.5. Thailand
  - 7.5.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.5.6. South Korea
  - 7.5.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.6. Latin America
- 7.6.1. Brazil
  - 7.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.6.2. Mexico
  - 7.6.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.6.3. Argentina
  - 7.6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.7. MEA
- 7.7.1. South Africa
  - 7.7.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.7.2. Saudi Arabia
  - 7.7.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.7.3. UAE
  - 7.7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.7.4. Kuwait
  - 7.7.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)

Chapter 8. Competitive Landscape

8.1. Recent Developments & Impact Analysis, By Key Market Participants
8.2. Market Participant Categorization
- 8.2.1. Carl Zeiss Meditec AG
  - 8.2.1.1. Company overview
  - 8.2.1.2. Financial performance
  - 8.2.1.3. Product benchmarking
  - 8.2.1.4. Strategic initiatives
- 8.2.2. Topcon Corporation
  - 8.2.2.1. Company overview
  - 8.2.2.2. Financial performance
  - 8.2.2.3. Product benchmarking
  - 8.2.2.4. Strategic initiatives
- 8.2.3. Heidelberg Engineering GmbH
  - 8.2.3.1. Company overview
  - 8.2.3.2. Financial performance
  - 8.2.3.3. Product benchmarking
  - 8.2.3.4. Strategic initiatives
- 8.2.4. Sonomed Escalon
  - 8.2.4.1. Company overview
  - 8.2.4.2. Financial performance
  - 8.2.4.3. Product benchmarking
  - 8.2.4.4. Strategic initiatives
- 8.2.5. Visbion
  - 8.2.5.1. Company overview
  - 8.2.5.2. Financial performance
  - 8.2.5.3. Product benchmarking
  - 8.2.5.4. Strategic initiatives
- 8.2.6. EyePACS, LLC
  - 8.2.6.1. Company overview
  - 8.2.6.2. Financial performance
  - 8.2.6.3. Product benchmarking
  - 8.2.6.4. Strategic initiatives
- 8.2.7. VersaSuite
  - 8.2.7.1. Company overview
  - 8.2.7.2. Financial performance
  - 8.2.7.3. Product benchmarking
  - 8.2.7.4. Strategic initiatives
- 8.2.8. Merge Healthcare Inc (IBM Watson Health)
  - 8.2.8.1. Company overview
  - 8.2.8.2. Financial performance
  - 8.2.8.3. Product benchmarking
  - 8.2.8.4. Strategic initiatives
- 8.2.9. ScImage, Inc.
  - 8.2.9.1. Company overview
  - 8.2.9.2. Financial performance
  - 8.2.9.3. Product benchmarking
  - 8.2.9.4. Strategic initiatives

안과용 의료영상저장전송시스템(PACS) 시장 규모, 점유율 및 동향 분석 보고서 : 유형별, 작용기전별, 최종 용도별, 지역별, 부문별 예측(2023-2030년)

Ophthalmology PACS Market Size, Share & Trends Analysis Report By Type (Integrated, Standalone), By Mode Of Action (Cloud-based, On-premise), By End-use (Hospitals, Specialty Clinics), By Region, And Segment Forecasts, 2023 - 2030

안과용 의료영상저장전송시스템(PACS) 시장의 성장과 동향 :

안과용 의료영상저장전송시스템(PACS) 시장 보고서 하이라이트

목차

제1장 조사 방법과 범위

제2장 주요 요약

제3장 안과용 의료영상저장전송시스템(PACS) 시장 변수, 동향, 범위

제4장 안과용 의료영상저장전송시스템(PACS) : 유형별 추정·동향 분석

제5장 안과용 의료영상저장전송시스템(PACS) : 작용기전별 추정·동향 분석

제6장 안과용 의료영상저장전송시스템(PACS) : 최종 용도별 추정·동향 분석

제7장 안과용 의료영상저장전송시스템(PACS) 시장 : 지역별 추정·동향 분석

제8장 경쟁 구도

Ophthalmology PACS Market Growth & Trends: